These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26932197)

  • 1. Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease.
    Feng Q; Liu Z; Zhong S; Li R; Xia H; Jie Z; Wen B; Chen X; Yan W; Fan Y; Guo Z; Meng N; Chen J; Yu X; Zhang Z; Kristiansen K; Wang J; Xu X; He K; Li G
    Sci Rep; 2016 Mar; 6():22525. PubMed ID: 26932197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Validation of Plasma Metabolomics Reveal Potential Biomarkers for Coronary Heart Disease.
    Fu H; Zhu K; Zhou D; Guan Y; Li W; Xu S
    Int Heart J; 2019 Nov; 60(6):1387-1397. PubMed ID: 31666452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral metagenomics combined with non-targeted serum metabolomics reveals the role of enteroviruses in a mouse model of coronary heart disease.
    Li X; Liu S; Wu H; Li B; Li Y; Li R; Tang D; Zhang H
    Virol J; 2024 Jul; 21(1):169. PubMed ID: 39080726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of metagenomics in the human gut microbiome.
    Wang WL; Xu SY; Ren ZG; Tao L; Jiang JW; Zheng SS
    World J Gastroenterol; 2015 Jan; 21(3):803-14. PubMed ID: 25624713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of metabolic biomarkers in patients with type 2 diabetic coronary heart diseases based on metabolomic approach.
    Liu X; Gao J; Chen J; Wang Z; Shi Q; Man H; Guo S; Wang Y; Li Z; Wang W
    Sci Rep; 2016 Jul; 6():30785. PubMed ID: 27470195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An LC-MS based untargeted metabolomics study identified novel biomarkers for coronary heart disease.
    Li R; Li F; Feng Q; Liu Z; Jie Z; Wen B; Xu X; Zhong S; Li G; He K
    Mol Biosyst; 2016 Oct; 12(11):3425-3434. PubMed ID: 27713999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of coronary heart disease biomarkers with different severities of coronary stenosis in human urine using non-targeted metabolomics based on UPLC-Q-TOF/MS.
    Huang M; Zhao H; Gao S; Liu Y; Liu Y; Zhang T; Cai X; Li Z; Li L; Li Y; Yu C
    Clin Chim Acta; 2019 Oct; 497():95-103. PubMed ID: 31325445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional pattern and signatures of gut microbiota in rural residents with coronary heart disease: A metagenomic analysis.
    Li W; Li H; Wang S; Han K; Liu Y; An Z; Wu H; Li J; Song J; Wu W
    Front Cell Infect Microbiol; 2022; 12():1007161. PubMed ID: 36519129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection and analysis on plasma metabolomics in patient with coronary heart disease of Xin-blood stasis syndrome pattern].
    Jian WX; Yuan ZK; Huang XP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jun; 30(6):579-84. PubMed ID: 20815270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseases.
    Lu J; Chen B; Chen T; Guo S; Xue X; Chen Q; Zhao M; Xia L; Zhu Z; Zheng L; Yin H
    Redox Biol; 2017 Aug; 12():899-907. PubMed ID: 28472752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of novel metabolites potentially involved in the pathogenesis of coronary heart disease using a UHPLC-QTOF/MS-based metabolomics approach.
    Li Y; Zhang D; He Y; Chen C; Song C; Zhao Y; Bai Y; Wang Y; Pu J; Chen J; Yang Y; Dou K
    Sci Rep; 2017 Nov; 7(1):15357. PubMed ID: 29127404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease.
    Ganna A; Salihovic S; Sundström J; Broeckling CD; Hedman AK; Magnusson PK; Pedersen NL; Larsson A; Siegbahn A; Zilmer M; Prenni J; Arnlöv J; Lind L; Fall T; Ingelsson E
    PLoS Genet; 2014 Dec; 10(12):e1004801. PubMed ID: 25502724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untargeted Metabolomics Profiling Reveals Perturbations in Arginine-NO Metabolism in Middle Eastern Patients with Coronary Heart Disease.
    Ullah E; El-Menyar A; Kunji K; Elsousy R; Mokhtar HRB; Ahmad E; Al-Nesf M; Beotra A; Al-Maadheed M; Mohamed-Ali V; Saad M; Al Suwaidi J
    Metabolites; 2022 Jun; 12(6):. PubMed ID: 35736450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in Faecal Metagenomics and Serum Metabolomics Indicate Management Strategies for Patients With Budd-Chiari Syndrome.
    Lu Q; Xu H; Zhou L; Zhang R; Li Z; Xu P; Bai T; Wang Z; Wu G; Ren J; Jiao D; Song Y; Zhu R; Li J; Wang W; Liang R; Li L; Ma X; Zu M; Sun Y
    Front Cell Infect Microbiol; 2021; 11():730091. PubMed ID: 34746022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic Characterization Analysis of Human Hepatocarcinoma by Urine Metabolomics Approach.
    Liang Q; Liu H; Wang C; Li B
    Sci Rep; 2016 Jan; 6():19763. PubMed ID: 26805550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis.
    Chen J; Wright K; Davis JM; Jeraldo P; Marietta EV; Murray J; Nelson H; Matteson EL; Taneja V
    Genome Med; 2016 Apr; 8(1):43. PubMed ID: 27102666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality.
    Chen Y; Guo J; Qian G; Fang D; Shi D; Guo L; Li L
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1429-37. PubMed ID: 25711972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential applications of metagenomics to assess the biological effects of food structure and function.
    Santiago-Rodriguez TM; Cano R; Jiménez-Flores R
    Food Funct; 2016 Oct; 7(10):4160-4169. PubMed ID: 27386789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A metabolomic profile is associated with the risk of incident coronary heart disease.
    Vaarhorst AA; Verhoeven A; Weller CM; Böhringer S; Göraler S; Meissner A; Deelder AM; Henneman P; Gorgels AP; van den Brandt PA; Schouten LJ; van Greevenbroek MM; Merry AH; Verschuren WM; van den Maagdenberg AM; van Dijk KW; Isaacs A; Boomsma D; Oostra BA; van Duijn CM; Jukema JW; Boer JM; Feskens E; Heijmans BT; Slagboom PE
    Am Heart J; 2014 Jul; 168(1):45-52.e7. PubMed ID: 24952859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
    Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
    Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.